US equities
|
MU
$918.21
▲+0.45%
NVDA
$217.91
▼-1.53%
SNDK
$1,369.72
▼-2.40%
SPCX
$146.87
▼-3.48%
AMD
$552.84
▼-3.15%
INTC
$95.07
▼-3.11%
TSM
$420.80
▼-2.14%
AAPL
$343.24
▲+0.08%
MU
$918.21
▲+0.45%
NVDA
$217.91
▼-1.53%
SNDK
$1,369.72
▼-2.40%
SPCX
$146.87
▼-3.48%
AMD
$552.84
▼-3.15%
INTC
$95.07
▼-3.11%
TSM
$420.80
▼-2.14%
AAPL
$343.24
▲+0.08%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Chris Garabedian
Recent news which mentions Chris Garabedian
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
April 15, 2022
Tickers
INNO
Tags
Insurance
Roundup
Kelly Beck
From
Business Journals